you all our care execute last progress has initiatives. us Since settings and key well thank across We outperformed the substantial joining Thanks, review in quarter secured first results. of new update exceptionally and team made continued across for to to orders our XXXX on revenue, our afternoon, March, everybody, Lynn. Good Outset operationally. strategic console
first was total growth we volume well the by expectations, growth year-over-year relative our driven quarter, For as $XX.X representing higher million product sequentially. primarily revenue, This and to as increased ASPs. XXX% reported outperformance, XX% in
first new consoles existing of lowering factors whether of to and continue in leading expand as we validation Tablo and is their increasing were acquisition experiences While than customer their value indicator expand In just the shipment provides metric well locations. important, an ease use of their network. facilities that sites watch positive consoles more to other ordered closely cost existing the a operating driving quarter, are to use for as customers our purchase of as is This within new additional tangible Tablo's and decision within economic new for XX% Customers Tablo's to customer appreciation to value as networks. cite efficiencies.
systems health by terms our of agreements and the the to receptivity our national to entire year. that commercial of systems well XXX and market a of several have of we signed during be regional Tablo end growth systems will the testament this future top goals these strength prospects. health organization Achieving of projecting a quarter new currently are as third seven top as the health the we with In added customers, will eight importantly,
we're expand to of starting As number a prominent health greater abstracts. publications and systems with adopt Tablo, see more and independent
HCA $XXX The savings Tablo. of and reported reported from for written For example, New cost with cost St. submitted abstract, the and per QX saw acuity patients example, success abstracts University These clinical UPMC, on and Tablo's a HCA. scientific Mexico treating to reduction. abstracts Mark's conferences treatment high
acute market. subacute and As include of the we past, facilities our the we've acute both in definition outlined in
focused Within acute well facilities skilled penetrating as subacute known long-term market, the nursing on facilities. as we're as care LTAC both
labor with supplies these proposition similar, is reduction cost value along Tablo operating customers, versatility. efficiency the For and and clinical
Our across four And country. communicated now fact, three largest sales is by of Tablo the advantages team the used these in to LTAC has LTACs successfully providers.
still have we're momentum acute early expect subacute our as While key proposition to by increasingly With base confident in considerable both and in economic simplicity that advantages. uptake continue data-rich it we adoption following expansion to the Tablo's runway, experience new our and We of clinical view our customer console installed is are terms we markets, growing customers versatility, stakeholders and the value LTAC deployment. resonating far. as acquisition, mobility, across pleased quickly the point-of-care benefits and of this build critical so unparalleled
footprint, expand population. grow move to our new we sequential a to we our have contracts we to This with which also master quarter, In home console four customers, signed continued the orders. in As XX% first in meet led growth home to part health position increase XXXX goals. and are in majority us contracts home innovative both progressive, our trajectory home helps spanning a traction customers and providers. dialysis our care The early puts anticipated our new of with systems home fuel good home
to itself In the way supports new system. dialysis while example, One this health model, focused program. their the disease to from the is up the own for home the preferred is cases, notable customers, kidney standing journey its on chronic is managing enabling hospital earlier and other home patients and the of identify manage health to provider all Tablo services home. for health the our systems dialysis home patient the technology, system In
home real-world interested important in become a provider's Tablo technology. is From exceptional. home those home currently evidence, we collect our remains an and fact, are in the that perspective, patient models, increasingly as we at data believe health In present proposition To-date, enabling value a third both at systems beginning tangible. from programs. In Tablo's of will pipeline
the it six takes patient to to continue or differentiated to Tablo, training to times two weeks We typically learn weeks highly see the on device. compared less patients four consistently incumbent
attrition. patient seen Additionally, much we have lower
incumbent and number a small is a rate to-date. example, home. documents of dropout that Tablo at patient Tablo patients, the training choose data we higher a device started still For XX% come not to seen have had on than on they very off once on while Moreover, published early
As it's our and we a certainly good to the grows, are increase, expect population that dropout proud start rate attaining. but we one patient very of
report the deliver These problems he most on of days continue us metrics, to cycle miles XX to that every now the per growth rate, really day motivate digital are time able We onerous qualitative transform patient the impact all continuing even features. training to and the impact on We on believe get that these We most have stories the vision to to HHD and marketing to seamless he for recently XX tech-enabled see Tablo patients' having forward attrition. training we lives intend represent our go are and have represent a and dialysis driven patients. and patients that the retention, a On is because into two a on the high the prevented level, to work look with support lives by biggest dialysis. we that to the activation, journey and another in they training day. dropout had past, to is vital historical back
cost exceptional to chain our of and focus long-term production vital for level on teams quality our activities, lift success. Tablo which continued reduction and have orders maintaining manufacturing of capacity are to build, both As an our supply while
in better-than-forecasted profit, in primary Our and gross manufacturing and facility state-of-the-art this production which alone, new in satisfy driver new was incorporates plan. ahead slightly second consoles continues to fully factory the Tijuana, XXX facility the half produced increasing, of remain consoles. leading Mexico, QX of The ramp, documentation over from a to our the team gross of XXX cloud-based second well manufacturing in outperformance system manufactured April schedule shift our margin. forecasted quarter to the This of year. positive we positioned With
related see second reduction benefit XXX(k) Asia later clearance we on as Tablo year expected in FDA half within to cost from production puts the new contract the shift track FDA XXXX, us application submitted March the to our in enable our to of Mexico timeframe. of and anticipated produce manufacturing to from assuming to The the submission Additionally, partner majority cartridges. to expected the this
three on XXXX. Looking objectives critical ahead, remain through we achieving focused
their a provide working for reduction customer accelerating and home an second, and First, for continuing activities the XXXX, to by more within current to expanding our systems, third, expansion. new margin to manufacturing drive deeply adoption while market And signing and agreements health exceptional incremental foundation families. home driving output significant ensure base focus gross increasing acute Tablo customer and growth patient on user in relationships national and patients bolster cost to growth capture regional with experience data, in
confident growth, than is more offering, With will settings. across the to The of ago. our follow-on in the care for year recent a which of above we adoption ability estimates are us Tablo help benefit our fund less internal revenue than our multiple ever proceeds tracking drive
initiatives. forward and Additionally, by performance, we marked the in demand subacute and see initiatives timing providers are settings With as progress operational we strategic durable quarter Tablo with strong cost XXXX Tablo across international time, for We data for confident beyond. same in manufacturing continued and first to remain for growth and and R&D, summary, uptaking our in care substantial profitability. of home, on with In a of console clear the various initiatives. acute execution long-term placements, number designed visibility are our performance with At and strong analytics drive well. was moving across the accelerating consistent Tablo our interest on positioning and home growing revenue track we reduction
our provide on of And the now the key so, to and for more turn Rebecca remainder drivers over and review expectations with our granularity that XXXX. to call I'll financials
